롱
Long TP at $2.50
ZGNX Brean initiation report (partial) Future Looks Brighter for Zogenix, Initiate with BUY and $2.50 TP Investment Summary
We are initiating coverage of Z, Inc. with a BUY rating and a $2.50 TP. Zogenix has commercialized
a controversial product, Z ER, and we believe the market under-appreciates the medical value this
product brings to patients and pain-treating specialists. Despite the heated debate and intense negative
coverage from the media, we are impressed that the product is performing well during early launch days.
We are initiating coverage of Z, Inc. with a BUY rating and a $2.50 TP. Zogenix has commercialized
a controversial product, Z ER, and we believe the market under-appreciates the medical value this
product brings to patients and pain-treating specialists. Despite the heated debate and intense negative
coverage from the media, we are impressed that the product is performing well during early launch days.
면책사항
이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.